ORF K14HHV8 (AA 111-210) antibody (AbBy Fluor® 555)
Quick Overview for ORF K14HHV8 (AA 111-210) antibody (AbBy Fluor® 555) (ABIN900657)
Target
Reactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 111-210
-
Cross-Reactivity
- Virus
-
Cross-Reactivity (Details)
- HHV 8 type M
-
Characteristics
- Antibody is specific for: HHV 8 type M
-
Purification
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human HHV8/ORF K14
-
Isotype
- IgG
-
-
-
-
Application Notes
-
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
Preservative
- ProClin
-
Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
Expiry Date
- 12 months
-
-
- ORF K14HHV8
-
Target Type
- Viral Protein
-
Background
-
Synonyms: NULL
Background: HHV8 has been found to be associated with three different diseases observed in AIDS patients, kaposi's sarcoma, primary effusion lymphoma (which is a rare type of non-Hodgkin lymphoma affecting the body cavities) and multicentric Castleman's disease. To date there is much evidence to support a direct role for HHV8 in kaposi's sarcoma.
Target
-